levofloxacin has been researched along with Latent Tuberculosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Behr, MA; Benedetti, A; Britton, WJ; Dowdy, DW; Fox, GJ; Graham, SM; Marais, BJ; Marks, GB; Mason, P; Menzies, D; Nguyen, BH; Nguyen, CB; Nguyen, TA; Nguyen, VN; Tran, PT; Velen, K | 1 |
Ader, F; Collardeau-Frachon, S; Gillet, Y; Huguet, A; Ohlmann, C | 1 |
Adler-Shohet, FC; Carson, M; Girma, H; Low, J; Singh, J | 1 |
Ader, F; Bouaziz, A; Catho, G; Dumitriescu, O; Pedone, C; Perpoint, T; Reix, P; Ronnaux-Baron, AS; Sénéchal, A; Valour, F | 1 |
Bamrah Morris, S; Brostrom, R; Chorba, T; Daley, CL; Fred, D; Gonzalez, D; Jereb, JA; Loeffler, AM; Martin, F; Mase, SR; Menon, LR; Peloquin, CA | 1 |
1 review(s) available for levofloxacin and Latent Tuberculosis
Article | Year |
---|---|
[Children exposed to multidrug-resistant tuberculosis: How should we manage? Analysis of 46 child contacts and review of the literature].
Topics: Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Female; France; Humans; Infant; Latent Tuberculosis; Levofloxacin; Lost to Follow-Up; Male; Tuberculosis, Multidrug-Resistant | 2015 |
1 trial(s) available for levofloxacin and Latent Tuberculosis
Article | Year |
---|---|
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Latent Tuberculosis; Levofloxacin; Male; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vietnam; Young Adult | 2020 |
3 other study(ies) available for levofloxacin and Latent Tuberculosis
Article | Year |
---|---|
Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Latent Tuberculosis; Levofloxacin; Male; Massive Hepatic Necrosis; Pyrazinamide; Tuberculosis, Multidrug-Resistant | 2019 |
Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis.
Topics: Adolescent; Antibiotic Prophylaxis; Antitubercular Agents; Child; Contact Tracing; Humans; Latent Tuberculosis; Levofloxacin; Pyrazinamide; Retrospective Studies; Tuberculosis, Multidrug-Resistant | 2014 |
Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Latent Tuberculosis; Levofloxacin; Male; Microbial Sensitivity Tests; Micronesia; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2016 |